|
HS Code |
533753 |
| CAS_Number | 524-42-5 |
| Molecular_Formula | C15H20N4O3 |
| Molecular_Weight | 304.35 g/mol |
| IUPAC_Name | 2-(hydroxymethyl)-6,7-dimethoxy-9H-purine-9-yl)oxolane-3,4-diol |
| Synonyms | Norcrassin, isolithoside |
| Appearance | White to off-white powder |
| Solubility | Soluble in DMSO, slightly soluble in water |
| Melting_Point | Approximately 225-227°C |
| Source | Natural product from Croton tiglium and related species |
| Biological_Activity | Reported nucleoside analog with cytotoxic and antiviral properties |
As an accredited Crotonoside factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Crotonoside is supplied in a 1g amber glass vial with a secure screw cap, labeled with safety information and product details. |
| Shipping | Crotonoside is shipped in tightly sealed containers, protected from light and moisture, and labeled according to regulatory standards. It is transported under ambient temperature, avoiding extreme conditions. Appropriate hazard labels ensure safe handling. Documentation accompanies the shipment, confirming chemical identity and safety precautions. Follow all local, national, and international shipping guidelines. |
| Storage | Crotonoside should be stored in a tightly sealed container, away from light and moisture, at a cool temperature (2–8°C, typically refrigerated). It should be kept in a well-ventilated, dry area, separate from incompatible substances. Proper labeling and secure storage are essential to ensure safety and chemical integrity. Avoid exposure to strong acids, bases, and oxidizing agents. |
Applications of Crotonoside in Industrial ManufacturingCrotonoside, a naturally occurring nucleoside analog, finds industrial use primarily as a specialty intermediate in regulated life science sectors. As the direct manufacturer, we supply crotonoside to a range of downstream formulators who depend on its molecular properties in highly controlled processes. The following scenarios illustrate actual industrial applications with strict adherence to regulatory, processing, and product standards. 1. Active Pharmaceutical Ingredient (API) Intermediate for Antineoplastic FormulationsPharmaceutical manufacturers incorporate crotonoside as a core intermediate in the synthesis of certain purine analog chemotherapies. Production batches require controlled integration of this nucleoside during API assembly to maintain molecular purity and comply with oncology formulation regulations. Expert planning of the integration step ensures that the molecule’s reactivity persists throughout the successive reactions necessary for antineoplastic agent production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Reference Standard Material for Chromatographic and Method Validation LaboratoriesAnalytical and quality control laboratories in pharmaceutical and biotechnological industries source crotonoside as an authenticated reference standard. It is pivotal for HPLC assay calibration, trace-level impurity profiling, and routine batch release validation. Continuous supply with solid documentation supports laboratories in globally regulated environments, helping ensure traceability and data integrity during critical validation work. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor for Nucleoside Analogue Libraries in Drug Discovery ResearchEarly-stage research programs rely on crotonoside’s molecular scaffold to generate libraries of novel nucleoside analogues. Medicinal chemistry teams utilize it for targeted derivatization during the construction of screening candidates for enzyme inhibition, antiviral, or immunomodulatory properties. Controlled supply allows research facilities to maintain high-throughput synthesis and scale pathway feasibility studies in compliance with laboratory oversight policies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cytotoxicity Positive Control in Biomedical Toxicological TestingBiomedical test kit manufacturers use crotonoside as an established positive control in cytotoxicity and cell viability assays. Its known effect profile provides reliable baseline data for cell response benchmarking in vitro, contributing to assay reproducibility in regulated testing environments. QC teams validate every control batch against documented cytotoxic endpoints to assure regulatory acceptance in toxicological studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Crotonoside prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working directly with the teams that design, operate, maintain, and improve our synthesis line means seeing Crotonoside not just as a product, but as an evolving result of applied chemical expertise. Each batch rolls off our reactor with lessons from the last—incremental tweaks in the reaction temperature, tighter moisture control, changes in solvent kicks based on recent analytical results.
Our chemists don’t just rely on theoretical reaction pathways for the synthesis. They look for those subtle signals—a shift in crystal structure, a change in color, a minor deviation in melting point—that only show up after hundreds of runs. Tight scrutiny by our internal quality group underpins every lot. The repeatability of our process comes straight from experience, not from cutting corners or claiming things we can’t prove in a real lab setting.
We produce Crotonoside using a multi-step organic synthesis, starting with selected raw materials that meet our established specifications. The compound offers a molecular formula of C11H12N4O4 and appears as a pale, crystalline solid at room temperature. Our process targets a purity above 99% by HPLC with moisture typically below 0.5%. With these characteristics, our Crotonoside answers to the needs of demanding research and formulation environments.
Beyond the chemical basics, providing Crotonoside means handling sensitive issues like trace contaminants and polymorphism. We support our claims with third-party testing and in-house chromatography—no batch ships without UV-Vis and NMR confirmations to back up our release criteria.
Years of feedback have shown us that what researchers and formulators mostly complain about is not the average purity, but inconsistency from lot to lot. Variability may not look dramatic on paper, but it throws off scaling studies or biological tests. Our teams keep logs down to each maintenance event or change in a filter, believing that process control beats clever marketing every time.
A key part of our value comes from producing Crotonoside that behaves identically across different shipments. Our experience shows that even a tiny excess of a solvent residue will change how the compound mixes in aqueous or organic stock solutions, and even minimal chiral impurity can ruin confidence in bioassay results. We don’t chase the highest theoretical assay—stable, reproducible performance means more in real-world labs.
We supply Crotonoside mainly to researchers working in nucleoside chemistry, enzyme inhibition assays, and cellular response screening. Many scientists choose this molecule for its unique pattern of biochemical activity, often looking for inhibition of DNA or RNA synthesis in model systems.
Ongoing feedback from university R&D labs reflects how critical it gets to trust the posted spec from older stocks. Someone halfway across the world might pick up a bottle after years in storage; if the NMR or LC data don’t match our records, they’ll know right away. Our built-in documentation allows you to see the full history and properties of your specific lot. Chemical R&D isn’t forgiving of vague or incomplete paper trails, and we keep that front of mind.
Working with Crotonoside means anticipating real-world lab conditions. Regular ethanol solutions, buffered saline, or DMSO stocks all take up Crotonoside with minimal agitation under standard conditions. That solubility behavior removes roadblocks for high-throughput screens or batch cell culture dosing.
Storage remains straightforward—airtight containers, away from direct sunlight in cool conditions. The molecule resists slow hydrolysis if left open to air, but we cap every bottle under inert atmosphere. Stability worries usually come from poorly prepared stocks—exposing the powder to humidity or high temperature creates visible clumps within a week, so we advise keeping aliquots small and dry. Real handlers know that small mistakes in storage cost days of troubleshooting; prevention saves far more time than rushing through sample prep.
A lot of nucleosides end up as bulk commodities, and the same can easily happen with Crotonoside if the manufacturer isn’t controlling the synthesis or purification steps. Many third-party suppliers offer material that only looks similar by paper chromatography; we’ve tested some of these lots and found co-eluting contaminants or misassignments in the spectra.
We stick to a defined synthesis route, with written protocols and a digital archive of every step. Regular cross-checks of the IR, NMR, and mass spectrometry signatures mean that we catch subtle deviations long before a lot leaves our site. We take nothing for granted—before a fresh batch goes out, it gets checked against both current and legacy standards to catch any drift in physical or chemical properties. In our experience, “almost identical” doesn’t cut it for critical experiments.
Most of our partners, whether universities or private firms, expect documentation that covers everything from the original CoA to impurity profiling. That expectation goes far beyond a typical product spec; auditors and grant reviewers look for a traceable record. We routinely keep digital certificates, manufacturing process records, and sample chromatograms on file for years after a lot ships.
This level of record-keeping comes from decades of inspections. Regulations and industry practices continue to get tighter. Trying to rebuild a product timeline from partial data or missing chromatograms causes delays, backtracking, and headaches for everyone. By maintaining a transparent record, we offer our partners a guarantee: what arrives in the bottle matches what they’ve seen on paper and in the lab, batch after batch.
Supplying Crotonoside doesn’t mean just selling a molecule—it means supporting real progress. Some researchers want to push concentrations beyond traditional solubility targets or need help finding the right buffer for a challenging enzyme test. Others run into problems with crystallization or need a new stability analysis. Our technical support team comes straight from the synthesis and quality control benches; sharing practical tips and experience is second nature for us.
Customers working in biotechnology or chemistry regularly ask for ideas to avoid common pitfalls—clusters forming in solution, NMR peak broadening, storage temperature guidelines, or batch-to-batch assay troubleshooting. After years at the bench ourselves, we know theory doesn’t always account for small environmental changes, human error, or hidden impurities. Passing on firsthand advice keeps users one step ahead.
The Crotonoside market gets crowded with varied levels of control. Cheap options often tempt buyers on price, but we’ve tested these samples for active impurities, unusual spectral noise, and high volatile residue. Our QC staff shares a running archive of off-spec materials collected over the years—mismatched NMR peaks, shifts in IR bands, and failures to crystallize as advertised.
Through these tests, we have learned that cost savings measured in cents or dollars rarely make up for rounds of failed experiments, lost grant money, or months of extra troubleshooting. Achieving confidence in research means more than following an HPLC curve—it means total traceability from raw material to finished bottle. Sometimes the difference proves subtle until real-world stress tests, but we have seen it pay dividends for repeat users who rely on consistent chemical properties for scaling or longitudinal studies.
Looking at the current chemical landscape, we notice recurring sources of headaches for researchers and process developers. Inconsistent melting points, residual solvent peaks visible by NMR, or incomplete documentation can lead to days—sometimes weeks—of stalled research. These issues don’t always appear during a routine purchase, but they tend to emerge when scaling up protocols or interpreting unexpected results. Our in-house team treats each deviation as an opportunity to improve—not just fix, but document the problem and prevent recurrence on future lots.
We have also noticed incomplete disclosure from some suppliers about storage or handling difficulties. Some materials arrive slightly off-color, with mysterious lumps or off odors. That points to either excess time in storage or incorrect packaging, both risks for those trying to replicate demanding protocols. We build feedback loops into our product cycle, actively collecting comments and complaints, then using those to update our shipping, storage, and process documentation. Our best improvements often stem from customer discoveries in the field rather than internal QA alone.
Handling production ourselves from raw material selection through final packaging gives us full authority to catch problems early. There’s no reliance on upstream vendors for purification or repackaging, meaning we can trace a sample backwards all the way to its basic inputs. Supply disruptions or unexpected changes in precursor quality trigger immediate process review and adjustment, not just downstream troubleshooting.
By manufacturing in-house, our team observes every step that impacts yield, purity, and the physical consistency of Crotonoside. That direct connection to every process change and raw material delivery means we don’t pass off uncertainty to our partners. Control over the supply chain ensures stable timelines and clear expectations; we communicate delays or changes directly, avoiding the surprises that often come when buying strictly through traders or brokers.
Requests for new analytical data have grown steadily—bio-pharma teams or regulatory officers increasingly want not just a purity figure, but detailed impurity profiles, chiral data, or extended stability information under varied conditions. We’ve invested in improved chromatographic profiling, accessible spectral archives stretching back years, and rapid-response staff who interpret data within hours. Many researchers appreciate snapshots of stability after exposure to light, air, or solvents besides water. These extra measures aren’t marketing extras—they’re key for those seeking regulatory approvals or repeatable scientific output.
Supporting real-world research teams means moving beyond minimum legal requirements. Adding value sometimes means running extra batches under alternative storage, mixing, or heating conditions, just to document what happens and share that knowledge. Record-keeping and transparency build a foundation of trust—especially in high-stakes research where the smallest irregularity brings work to a halt.
Over several decades producing specialty chemicals, we’ve learned that staying static means falling behind. Problems show up in unpredictable ways: a hot summer shipment, a slight shift in a synthesis solvent, an unnoticed packaging change from a bottle supplier. Each one becomes a data point to explain, share and—most importantly—to fix. Not every issue stems from the compound itself; sometimes lab practices, instrument calibration, or sample handling introduce avoidable errors, and our job is to help identify the real source.
Our best recent improvements emerged from direct conversations with research partners—adding more robust inner seals, updating melting point tolerance in our CoAs, and re-testing sub-samples after extended overseas transit. In this way, Crotonoside becomes not only a catalog product but a reflection of our accumulated field experience as manufacturers who care about every experiment that depends on our quality.
Chemistry and biotechnology develop fast, making long-term stability the number one attribute demanded by lab teams. We’ve learned to anticipate requirements for new applications—addition of more detailed stability data, tighter moisture controls, or cleaner packaging—all based on unpredictable feedback from researchers whose work shapes our next improvements.
Working directly with the synthesis and analysis processes sharpens our ability to catch new trends—shifting impurity profiles tied to raw material sources, updates to international pharmacopeia requirements, or better sampling techniques that catch subtle variability before it reaches a customer. Staying engaged shows in every batch of Crotonoside that rolls out the door—proven by real analysis, transparent records, and partnerships with those doing the daily work that pushes science forward.
We see Crotonoside as a shared commitment. Every bottle carries both a piece of our process and the intent to meet the evolving needs of research and manufacture. Customers demand more than just another nucleoside—they want knowledge, a responsive partner, and the confidence that every experiment or manufacturing run has the full reliability of experience behind it. Our goal is simple: to make sure those counting on our Crotonoside never encounter unpleasant surprises, and always get the transparent support required for their best work. Unlike middlemen, we own the full story from synthesis to shipment, and back it up with real evidence.